BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 12673891)

  • 1. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Skowronski J; Cylwik JP; Cylwik B; Chwiecko J
    J Rheumatol; 2005 Sep; 32(9):1666-72. PubMed ID: 16142858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
    J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Ann Rheum Dis; 2002 Sep; 61(9):804-9. PubMed ID: 12176805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokines in different histological variants of rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
    J Rheumatol; 2001 Jun; 28(6):1211-7. PubMed ID: 11409111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Ann Rheum Dis; 2003 May; 62(5):472-5. PubMed ID: 12695163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H; Robak E
    Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6, soluble interleukin-2-receptor and soluble interleukin-6-receptor in sera of patients with rheumatoid arthritis: influences of disease activity and drug therapy.
    Franke S; Herrmann D; Hein G; Müller A; Stein G
    Eur J Med Res; 1997 Sep; 2(9):401-6. PubMed ID: 9300938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
    Rheumatology (Oxford); 2002 Jan; 41(1):78-87. PubMed ID: 11792884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.
    Matsumoto T; Iwasaki K
    Ann Rheum Dis; 1993 Dec; 52(12):876-80. PubMed ID: 8311539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
    Kotake S; Sato K; Kim KJ; Takahashi N; Udagawa N; Nakamura I; Yamaguchi A; Kishimoto T; Suda T; Kashiwazaki S
    J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interleukin-6 (IL-6), soluble interleukin-2-receptor (sIL-2R) and microheterogeneity of alpha-! acid glycoprotein (AGP): new markers of the acute-phase reaction?].
    Karrer U; Aeschlimann A; Fassbender K; Vogt P; Müller W
    Schweiz Med Wochenschr; 1992 Feb; 122(7):233-6. PubMed ID: 1539125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokinin panel in rheumatoid arthritis and correlation with histological patterns of synovitis -- active type of disease.
    Avrămescu C; Vere CC; Mărgăritescu C; Turculeanu A; Bălăşoiu M; Rogoz S
    Rom J Morphol Embryol; 2005; 46(2):87-92. PubMed ID: 16286991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters.
    Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
    Clin Exp Rheumatol; 1996; 14(4):413-6. PubMed ID: 8871841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
    Neidhart M; Müller-Ladner U; Frey W; Bosserhoff AK; Colombani PC; Frey-Rindova P; Hummel KM; Gay RE; Häuselmann H; Gay S
    Osteoarthritis Cartilage; 2000 May; 8(3):222-9. PubMed ID: 10806050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab.
    Diaz-Torne C; Ortiz MDA; Moya P; Hernandez MV; Reina D; Castellvi I; De Agustin JJ; Fuente D; Corominas H; Sanmarti R; Zamora C; Cantó E; Vidal S
    Semin Arthritis Rheum; 2018 Jun; 47(6):757-764. PubMed ID: 29157669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-soluble folate receptor β as a biomarker for the activity of rheumatoid arthritis synovitis and the response to anti-TNF agents.
    Otsubo H; Tsuneyoshi Y; Nakamura T; Matsuda T; Komiya S; Matsuyama T
    Clin Rheumatol; 2018 Nov; 37(11):2939-2945. PubMed ID: 30022370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis.
    Suenaga Y; Yasuda M; Yamamoto M; Nonaka S; Wada T; Shiokawa S; Nobunaga M
    Clin Rheumatol; 1998; 17(4):311-7. PubMed ID: 9776115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.